Researchers developed a dual-modality imaging system that combines high-resolution structural and chemical analysis with AI to improve skin cancer diagnosis.
Key Details
- 1The system merges line-field confocal optical coherence tomography (LC-OCT) with confocal Raman microspectroscopy.
- 2Over 330 nonmelanoma skin cancer samples were examined in a year-long clinical study.
- 3AI models trained on chemical spectra achieved classification accuracy of 0.95 for basal cell carcinoma and 0.92 for both basal and squamous cell carcinoma.
- 4The approach allows targeted, noninvasive analysis of suspicious skin structures at cellular and molecular levels.
Why It Matters
This innovation promises less invasive, more accurate skin cancer diagnosis by combining structural and biochemical imaging with AI classification, potentially reducing reliance on biopsies and improving patient outcomes.
Source
EurekAlert
Related News
•EurekAlert
MIT Introduces Interactive AI System for Fast Medical Image Annotation
MIT researchers have developed MultiverSeg, an interactive AI tool enabling efficient, user-driven segmentation of biomedical image datasets without prior model training.
•EurekAlert
Study Finds Gaps in FDA Safety Reporting for AI Medical Devices
A study highlights insufficient standardized safety and efficacy assessments for FDA-cleared AI/ML medical devices.
•EurekAlert
MSK Research: Proton Therapy, AI Pain Summaries, and Tumor Metastasis Insights
MSK Cancer Center research advances include proton therapy for leptomeningeal metastasis and evaluating large language models for cancer pain summary.